Ondansetrn ODT 4MG 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FX0LR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,416
Award facts
- Contract value 100% obligated
- $10,415.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,415.76 to Amerisourcebergen Drug Corp for the supply of Ondansetron Orally Disintegrating Tablets 4MG in a 30-count package. This competitively awarded, firm fixed-price contract has no set-aside designation and was issued on February 4, 2026, with an ultimate completion date of February 5, 2026. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings to manage nausea and vomiting, particularly for patients undergoing chemotherapy or experiencing post-operative symptoms.
This delivery order is a child contract issued under Amerisourcebergen Drug Corp's parent company, Cencora, Inc. (formerly Amerisourcebergen), which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a vast range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide. Amerisourcebergen's consistent receipt of competitively awarded delivery orders across multiple therapeutic domains demonstrates the company's established capability to efficiently fulfill critical pharmaceutical procurement requirements for federal military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FX0LR?
SPE2DR26FX0LR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FX0LR worth?
The government has obligated $10,416 on SPE2DR26FX0LR.
Is contract SPE2DR26FX0LR an order under another contract?
Yes. SPE2DR26FX0LR is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FX0LR competed?
The extent of competition for SPE2DR26FX0LR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award